<DOC>
	<DOCNO>NCT00274521</DOCNO>
	<brief_summary>The study design determine whether tiotropium inhalation capsule , compare placebo , enhance improvement exercise tolerance see patient chronic obstructive pulmonary disease ( COPD ) participate pulmonary rehabilitation . In addition , assessment effect tiotropium dyspnea quality life follow pulmonary rehabilitation take .</brief_summary>
	<brief_title>Tiotropium ( Spiriva ) Rehabilitation Study</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<criteria>History COPD , FEV1 le equal 60 % predict normal less equal 70 % Visit 1 , Male Female 40 year great , smoke history 10 pack year ( current exsmokers ) , patient perform study related test , patient inhale medication HandiHaler meter dose inhaler , patient would benefit participation pulmonary rehab program patient medical clearance participate pulmonary rehab program . Patients significant disease COPD , patient clinically relevant abnormal baseline hematology , blood chemistry urinalysis , patient SGOT great 80IU/L , bilirubin great 2.0 mg/dl creatinine great 2.0 mg/dL , recent history MI ( 6 month less ) . cardiac arrhythmia require drug therapy abeen hospitalize heart failure past 3 year , active TB , history CA treatment within last 24 month , history CF , bronchiectasis , interstitial lung disease pulmonary thromboembolic disease .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>